Bal Pharma Standalone December 2022 Net Sales at Rs 76.56 crore, up 10.97% Y-o-Y
February 07, 2023 / 18:24 IST
Reported Standalone quarterly numbers for Bal Pharma are:Net Sales at Rs 76.56 crore in December 2022 up 10.97% from Rs. 68.99 crore in December 2021.
Quarterly Net Profit at Rs. 1.47 crore in December 2022 up 20.82% from Rs. 1.22 crore in December 2021.
EBITDA stands at Rs. 7.08 crore in December 2022 down 1.8% from Rs. 7.21 crore in December 2021.
Bal Pharma EPS has increased to Rs. 0.94 in December 2022 from Rs. 0.82 in December 2021.
| Bal Pharma shares closed at 82.15 on February 06, 2023 (NSE) and has given -16.04% returns over the last 6 months and -34.90% over the last 12 months. |
| Bal Pharma | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'22 | Sep'22 | Dec'21 | | Net Sales/Income from operations | 76.56 | 75.05 | 68.99 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 76.56 | 75.05 | 68.99 | | EXPENDITURE | | Consumption of Raw Materials | 38.89 | 45.05 | 41.74 | | Purchase of Traded Goods | 3.84 | 2.29 | 2.65 | | Increase/Decrease in Stocks | 0.47 | -5.72 | -6.34 | | Power & Fuel | -- | -- | -- | | Employees Cost | 13.21 | 13.45 | 11.54 | | Depreciation | 2.03 | 1.96 | 1.71 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 13.85 | 13.98 | 13.30 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 4.28 | 4.05 | 4.39 | | Other Income | 0.77 | 0.38 | 1.11 | | P/L Before Int., Excpt. Items & Tax | 5.05 | 4.43 | 5.50 | | Interest | 3.12 | 2.83 | 2.36 | | P/L Before Exceptional Items & Tax | 1.93 | 1.60 | 3.14 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 1.93 | 1.60 | 3.14 | | Tax | 0.46 | 0.47 | 1.93 | | P/L After Tax from Ordinary Activities | 1.47 | 1.13 | 1.22 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 1.47 | 1.13 | 1.22 | | Equity Share Capital | 15.69 | 15.57 | 14.82 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 0.94 | 0.72 | 0.82 | | Diluted EPS | 0.95 | 0.73 | 0.82 | | EPS After Extra Ordinary | | Basic EPS | 0.94 | 0.72 | 0.82 | | Diluted EPS | 0.95 | 0.73 | 0.82 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
